Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 2
1996 3
1997 3
1998 1
1999 3
2000 3
2001 1
2002 3
2003 3
2004 6
2005 1
2006 1
2008 2
2009 2
2010 2
2011 4
2012 1
2013 1
2015 2
2017 1
2018 1
2019 1
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
In vivo imaging of alpha-synuclein with antibody-based PET.
Roshanbin S, Xiong M, Hultqvist G, Söderberg L, Zachrisson O, Meier S, Ekmark-Lewén S, Bergström J, Ingelsson M, Sehlin D, Syvänen S. Roshanbin S, et al. Among authors: zachrisson o. Neuropharmacology. 2022 May 1;208:108985. doi: 10.1016/j.neuropharm.2022.108985. Epub 2022 Feb 8. Neuropharmacology. 2022. PMID: 35149134 Free article.
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease.
Johannesson M, Sahlin C, Söderberg L, Basun H, Fälting J, Möller C, Zachrisson O, Sunnemark D, Svensson A, Odergren T, Lannfelt L. Johannesson M, et al. Among authors: zachrisson o. Mol Cell Neurosci. 2021 Jul;114:103641. doi: 10.1016/j.mcn.2021.103641. Epub 2021 Jun 4. Mol Cell Neurosci. 2021. PMID: 34091073
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease.
Nordström E, Eriksson F, Sigvardson J, Johannesson M, Kasrayan A, Jones-Kostalla M, Appelkvist P, Söderberg L, Nygren P, Blom M, Rachalski A, Nordenankar K, Zachrisson O, Amandius E, Osswald G, Moge M, Ingelsson M, Bergström J, Lannfelt L, Möller C, Giorgetti M, Fälting J. Nordström E, et al. Among authors: zachrisson o. Neurobiol Dis. 2021 Dec;161:105543. doi: 10.1016/j.nbd.2021.105543. Epub 2021 Nov 1. Neurobiol Dis. 2021. PMID: 34737044 Free article.
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients.
Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, Svenningsson P, Widner H, Frisén J, Pålhagen S, Haegerstrand A. Paul G, et al. Among authors: zachrisson o. J Clin Invest. 2015 Mar 2;125(3):1339-46. doi: 10.1172/JCI79635. Epub 2015 Feb 17. J Clin Invest. 2015. PMID: 25689258 Free PMC article. Clinical Trial.
Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study.
Van Damme P, Tilkin P, Mercer KJ, Terryn J, D'Hondt A, Herne N, Tousseyn T, Claeys KG, Thal DR, Zachrisson O, Almqvist P, Nuttin B, Jerling M, Bernadotte F, Haegerstrand A, Robberecht W. Van Damme P, et al. Among authors: zachrisson o. Brain Commun. 2020 Sep 29;2(2):fcaa160. doi: 10.1093/braincomms/fcaa160. eCollection 2020. Brain Commun. 2020. PMID: 33977260 Free PMC article.
No evident neuronal damage after electroconvulsive therapy.
Zachrisson OC, Balldin J, Ekman R, Naesh O, Rosengren L, Agren H, Blennow K. Zachrisson OC, et al. Psychiatry Res. 2000 Oct 30;96(2):157-65. doi: 10.1016/s0165-1781(00)00202-x. Psychiatry Res. 2000. PMID: 11063788
52 results